Kathryn Jean Boor Sarepta Therapeutics, Inc. (SRPT) insider trading activity

Kathryn Jean Boor is of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 7,516 shares of SRPT, which is worth approximately $859,229. The most recent transaction as insider was on Mar 11, 2024, when has been sold 761 shares (Common Stock) at a price of $122.93 per share, resulting in proceeds of $93,549. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.52K

0% 3M change

16.87% 12M change

Total Value Held $859,229

Kathryn Jean Boor Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 11 2024	SELL Open market or private sale	$93,549 $122.93 p/Share	761 Reduced 9.19%	7,516 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	1,846 Added 18.24%	8,277 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	1,523 Added 19.15%	6,431 Common Stock
Jun 02 2022	BUY Grant, award, or other acquisition	-	4,908 Added 50.0%	4,908 Common Stock

Also insider at

IFF

INTERNATIONAL FLAVORS & FRAGRANCES INC Basic Materials

Director

KJB